| 1 |
Breier D, Peer D. Genome editing in cancer: Challenges and potential opportunities. Bioactive Materials 2023;21:394-402. [DOI: 10.1016/j.bioactmat.2022.08.013] [Reference Citation Analysis]
|
| 2 |
Zhang YQ, Guo RR, Chen YH, Li TC, Du WZ, Xiang RW, Guan JB, Li YP, Huang YY, Yu ZQ, Cai Y, Zhang P, Ling GX. Ionizable drug delivery systems for efficient and selective gene therapy. Mil Med Res 2023;10:9. [PMID: 36843103 DOI: 10.1186/s40779-023-00445-z] [Reference Citation Analysis]
|
| 3 |
Abdellatif AAH, Younis MA, Alsowinea AF, Abdallah EM, Abdel-Bakky MS, Al-Subaiyel A, Hassan YAH, Tawfeek HM. Lipid nanoparticles technology in vaccines: Shaping the future of prophylactic medicine. Colloids Surf B Biointerfaces 2023;222:113111. [PMID: 36586237 DOI: 10.1016/j.colsurfb.2022.113111] [Reference Citation Analysis]
|
| 4 |
Iacomino G. miRNAs: The Road from Bench to Bedside. Genes (Basel) 2023;14. [PMID: 36833241 DOI: 10.3390/genes14020314] [Reference Citation Analysis]
|
| 5 |
Golubovic A, Tsai S, Li B. Bioinspired Lipid Nanocarriers for RNA Delivery. ACS Bio Med Chem Au 2023. [DOI: 10.1021/acsbiomedchemau.2c00073] [Reference Citation Analysis]
|
| 6 |
Nicholson TA, Sagmeister M, Wijesinghe SN, Farah H, Hardy RS, Jones SW. Oligonucleotide Therapeutics for Age-Related Musculoskeletal Disorders: Successes and Challenges. Pharmaceutics 2023;15. [PMID: 36678864 DOI: 10.3390/pharmaceutics15010237] [Reference Citation Analysis]
|
| 7 |
Li Z, Carter J, Santos L, Webster C, van der Walle CF, Li P, Rogers SE, Lu JR. Acidification-Induced Structure Evolution of Lipid Nanoparticles Correlates with Their In Vitro Gene Transfections. ACS Nano 2023;17:979-90. [PMID: 36608273 DOI: 10.1021/acsnano.2c06213] [Reference Citation Analysis]
|
| 8 |
González-Rioja R, Salazar VA, Bastús NG, Puntes V. The development of highly dense highly protected surfactant ionizable lipid RNA loaded nanoparticles. Front Immunol 2023;14:1129296. [PMID: 36923400 DOI: 10.3389/fimmu.2023.1129296] [Reference Citation Analysis]
|
| 9 |
Xin X, Huang W. mRNA-Based Cancer Therapy and Challenges. Handbook of Cancer and Immunology 2023. [DOI: 10.1007/978-3-030-80962-1_204-1] [Reference Citation Analysis]
|
| 10 |
Deng T, Hasan I, Roy S, Liu Y, Zhang B, Guo B. Advances in mRNA nanomedicines for malignant brain tumor therapy. Smart Materials in Medicine 2022. [DOI: 10.1016/j.smaim.2022.11.001] [Reference Citation Analysis]
|
| 11 |
Kairuz D, Samudh N, Ely A, Arbuthnot P, Bloom K. Advancing mRNA technologies for therapies and vaccines: An African context. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1018961] [Reference Citation Analysis]
|
| 12 |
Jiang Z, Fu M, Zhu D, Wang X, Li N, Ren L, He J, Yang G. Genetically modified immunomodulatory cell-based biomaterials in tissue regeneration and engineering. Cytokine Growth Factor Rev 2022:S1359-6101(22)00039-9. [PMID: 35690567 DOI: 10.1016/j.cytogfr.2022.05.003] [Reference Citation Analysis]
|
| 13 |
Vervaeke P, Borgos SE, Sanders NN, Combes F. Regulatory guidelines and preclinical tools to study the biodistribution of RNA therapeutics. Adv Drug Deliv Rev 2022;184:114236. [PMID: 35351470 DOI: 10.1016/j.addr.2022.114236] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 14 |
Aliahmad P, Miyake-Stoner SJ, Geall AJ, Wang NS. Next generation self-replicating RNA vectors for vaccines and immunotherapies. Cancer Gene Ther 2022. [PMID: 35194198 DOI: 10.1038/s41417-022-00435-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 15 |
Su C, See DHW, Huang J. Lipid-Based Nanocarriers in Renal RNA Therapy. Biomedicines 2022;10:283. [DOI: 10.3390/biomedicines10020283] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 16 |
Tariq H, Batool S, Asif S, Ali M, Abbasi BH. Virus-Like Particles: Revolutionary Platforms for Developing Vaccines Against Emerging Infectious Diseases. Front Microbiol 2021;12:790121. [PMID: 35046918 DOI: 10.3389/fmicb.2021.790121] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
|
